Assessment
nivolumab
Adults with unresectable or metastatic microsatellite-instable (MSI-H) or mismatch repair deficient (dMMR) colorectal carcinoma that has progressed after prior fluoropyrimidine-based combination therapy
- Modules
- IQWiG assessments · G-BA decisions
- Connections
- 2
Connected evidence
2 relations